Clinical Features, Socioeconomic Status, Management, and Outcomes of Acute Heart Failure: PEACE MENA Registry Phase I Results.


Journal

Current vascular pharmacology
ISSN: 1875-6212
Titre abrégé: Curr Vasc Pharmacol
Pays: United Arab Emirates
ID NLM: 101157208

Informations de publication

Date de publication:
2023
Historique:
received: 13 11 2022
revised: 29 03 2023
accepted: 04 05 2023
medline: 26 9 2023
pubmed: 26 5 2023
entrez: 26 5 2023
Statut: ppublish

Résumé

PEACE MENA (Program for the Evaluation and Management of Cardiac Events in the Middle East and North Africa) is a prospective registry in Arab countries for in-patients with acute myocardial infarction (AMI) or acute heart failure (AHF). Here, we report the baseline characteristics and outcomes of in-patients with AHF who were enrolled during the first 14 months of the recruitment phase. A prospective, multi-centre, multi-country study including patients hospitalized with AHF was conducted. Clinical characteristics, echocardiogram, BNP (B-type natriuretic peptide), socioeconomic status, management, 1-month, and 1-year outcomes are reported. Between April 2019 and June 2020, a total of 1258 adults with AHF from 16 Arab countries were recruited. Their mean age was 63.3 (±15) years, 56.8% were men, 65% had monthly income ≤US$ 500, and 56% had limited education. Furthermore, 55% had diabetes mellitus, 67% had hypertension; 55% had HFrEF (heart failure with reduced ejection fraction), and 19% had HFpEF (heart failure with preserved ejection fraction). At 1 year, 3.6% had a heart failure-related device (0-22%) and 7.3% used an angiotensin receptor neprilysin inhibitor (0-43%). Mortality was 4.4% per 1 month and 11.77% per 1-year post-discharge. Compared with higher-income patients, lower-income patients had a higher 1-year total heart failure hospitalization rate (45.6 vs 29.9%, p=0.001), and the 1-year mortality difference was not statistically significant (13.2 vs 8.8%, p=0.059). Most of the patients with AHF in Arab countries had a high burden of cardiac risk factors, low income, and low education status with great heterogeneity in key performance indicators of AHF management among Arab countries.

Identifiants

pubmed: 37231723
pii: CVP-EPUB-132060
doi: 10.2174/1570161121666230525111259
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

257-267

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Hanan AlBackr (H)

Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud Medical City, King Saud University, Riyadh, Saudi Arabia.

Khalid F Alhabib (KF)

Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud Medical City, King Saud University, Riyadh, Saudi Arabia.

Kadhim Sulaiman (K)

National Heart Center - Royal Hospital, Muscat, Oman.

Amal Jamee (A)

Nassar Medical Complex Hospital, Ministry of Health, Khan Younes, Gaza Strip, Palestine.

Mohamed Sobhy (M)

International Cardiac Center (ICC), Alexandria, Egypt.

Salim Benkhedda (S)

COCRG Laboratory, Cardiology Department, Mustapha Hospital, Benyoucef Benkhedda University, Algiers, Algeria.

Sobhi Dada (S)

Cardiology Department, Hammoud Hospital University Medical Centre, Saida, Lebanon.

Ayman Hammoudeh (A)

Cardiology Department, Istishari Hospital, Amman, Jordan.

Habib Gamra (H)

Research Laboratory LR 12SP16, Fattouma Bourguiba University Hospital, University of Monastir, Monastir, Tunisia.

Ahmed Al-Motarreb (A)

Faculty of Medicine, Sana'a University, Yemen.

Fahad Alkindi (F)

Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Mohammad I Amin (MI)

Mohamed Bin Khalifa Cardiac Centre, Bahrain.

Magdi G Yousif (MG)

Sudan Heart Centre, Khartoum, Sudan.

Hasan A Farhan (HA)

Iraqi Board for Medical Specializations, Baghdad Heart Center, Baghdad, Iraq.

Nadia Fellat (N)

Cardiology A department, Pole of Cardio Pneumology and Cardiothoracic Surgery, Ibn Sina University Hospital, Faculty of Medicine and Pharmacology of Rabat (FMPR), University Med V, Rabat, Morocco.

Wael Almahmeed (W)

Heart and Vascular Institute, Cleveland Clinic, Abu Dhabi, United Arab Emirates.

Mohammad Al Jarallah (MA)

Sabah Al Ahmed Cardiac Center, Kuwait.

Prashanth Panduranga (P)

National Heart Center - Royal Hospital, Muscat, Oman.

Magdy Abdelhamid (M)

Faculty of Medicine, Kasr Al Ainy Hospital, Cairo University, Cairo, Egypt.

Ihab Ghaly (I)

Alhyatt Heart and Vascular Center, Alexandria, Egypt.

Dahlia Djermane (D)

COCRG Laboratory, Cardiology Department, Mustapha Hospital, Benyoucef Benkhedda University, Algiers, Algeria.

Ahcene Chibane (A)

Internal Medicine and Cardiology Department, CHU Douéra, University Saad Dahlab, Blida, Algeria.

Hadi Skouri (H)

Cardiology Division - Internal Medicine Department at the American University of Beirut Medical Center, Beirut, Lebanon.

Mohamad Jarrah (M)

Division of Cardiology, Internal Medicine Department, King Abdullah University Hospital, Jordan University of Science and Technology, Irbid, Jordan.

Hassen Amor (H)

Cardiology Department, Taher Sfar University Hospital, Mahdia, Tunisia.

Nora K Alsagheer (NK)

Cardiology Department, Faculty of medicine, Sanaa University, Sanaa, Yemen.

Mohammed A Hozayen (MA)

Cardiology Department, Arass General Hospital, Arass, Al Qaseem, Saudi Arabia.

Hosameldin S Ahmed (HS)

Heart Hospital, Hamad Medical Corporation, Doha, Qatar.

Muhammad Ali (M)

Saudi Heart Association, Riyadh, Saudi Arabia.

Anhar Ullah (A)

Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud Medical City, King Saud University, Riyadh, Saudi Arabia.
National Heart and Lung Institute, Imperial College London, London, UK.

Ayman Al Saleh (AA)

Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud Medical City, King Saud University, Riyadh, Saudi Arabia.

Faiez Zannad (F)

Centre d'Investigation Clinique Inserm, Institut Lorrain du Coeur et des Vaisseaux, CHU, Université de Lorraine, Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH